Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:GENE?
Track your performance easily
GB:GENE Price & Analysis
GENE ETF Chart & Stats
Day’s Range― - ―
52-Week Range1,263.80p - 1,533.26p
Previous Close1,532.4p
VolumeN/A
Average Volume (3M)442.00
AUM99.47M
NAV19.11
Expense Ratio0.20%
Holdings Count104
Beta0.88
Inception DateDec 19, 2017
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding5,242,903
Standard Deviation0.05
10 Day Avg. Volume243
30 Day Avg. Volume442
Alpha0.01
Global Gender Equality UCITS ETF Accum A USD (GENE) Fund Flow Chart
Global Gender Equality UCITS ETF Accum A USD (GENE) 1 year Net Flows: -85M
GENE ETF News
GENE ETF FAQ
What was GB:GENE’s price range in the past 12 months?
GB:GENE lowest ETF price was 1263.80p and its highest was 1533.26p in the past 12 months.
What is the AUM of GB:GENE?
As of May 07, 2024 The AUM of GB:GENE is 99.47M.
Is GB:GENE overvalued?
According to Wall Street analysts GB:GENE’s price is currently Undervalued.
Does GB:GENE pay dividends?
GB:GENE does not currently pay dividends.
How many shares outstanding does GB:GENE have?
GB:GENE has 5,242,903 shares outstanding.
Which hedge fund is a major shareholder of GB:GENE?
Currently, no hedge funds are holding shares in GB:GENE
GENE ETF Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Pinterest
1.41%
Lyft Inc
1.37%
Meta Platforms, Inc.
1.35%
Citigroup Inc
1.33%
Publicis Groupe SA (UK)
1.30%
Xylem Inc
1.29%
American Express Company
1.27%
Wells Fargo & Company
1.27%
Schneider Electric SE (UK)
1.24%
Boston Scientific
1.23%
Total13.07%
ETF Description
Global Gender Equality UCITS ETF Accum A USD
The investment objective is to replicate the price and return performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index net of fees.